Acute Kidney Injury and Acute Kidney Disease in COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

900 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-21

Study Completion Date

2025-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute kidney injury (AKI) has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of AKI and renal recovery of inpatients diagnosed with COVID-19.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Acute Kidney Injury in Patients With CoVID-19

NCT04872764

Covid19 Acute Kidney Injury

COMPLETED

Kidney in Coronavirus Disease 2019 Registry

NCT04797091

Corona Virus Infection SARS-CoV 2

COMPLETED

Acute Kidney Injury in Patients Hospitalized With COVID-19

NCT04316299

COVID-19 Acute Kidney Injury Kidney Function

COMPLETED

Acute KIDnEy Injury in CoviD-19

NCT04583293

Acute Kidney Injury

COMPLETED

Acute Kidney Injury in Critical COVID-19: Outcomes and Risks

NCT07089693

COVID -19 Acute Kidney Injury Intensive Care Unit (ICU) Admission +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Beginning in December 2019, a novel coronavirus, designated as severe acute respiratory distress coronavirus 2 (SARS-CoV-2), has caused an international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19). Although the clinical manifestations of COVID-19 are dominated by respiratory symptoms, some patients show severe kidney abnormalities. Acute kidney injury (AKI) has been identified as an independent risk factor for in-hospital mortality. The present study aims to investigate the incidence of AKI and renal recovery of inpatients diagnosed with COVID-19.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Kidney Injury Corona Virus Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICU patients

Inpatients with COVID-19 requiring ICU care

No interventions assigned to this group

Non-ICU patients

Inpatients with COVID-19 not requiring ICU care

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1\) Patients with COVID-19 diagnosed by World Health Organisation (WHO) criteria

Exclusion Criteria

1. Patients aged less than 18 years
2. Patients with stage 4 chronic kidney disease (baseline estimated glomerular filtration rate \<30 ml/min/1.73 m2)
3. Patients receiving maintenance dialysis
4. Recipients of solid-organ transplantation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No